HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- ((N- (2,3,4,5,6- pentafluorocinnamoyl)- O- (2,6- dichlorobenzyl))tyrosyl)- 4- (bis(diethoxyphosphono))methylaminiopiperidine

a survivin inhibitor that inhibits bone metastatic growth of prostate cancer cells; structure in first source
Also Known As:
BKM 1740; BKM-1740; BKM1740
Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chung, Leland W K: 1 article (10/2008)
2. Gera, Lajos: 1 article (10/2008)
3. Iqbal, Shareen: 1 article (10/2008)
4. Johnson, Nicole A: 1 article (10/2008)
5. Qian, Wei Ping: 1 article (10/2008)
6. Seo, Seong Il: 1 article (10/2008)
7. Stewart, John: 1 article (10/2008)
8. Wang, Ruoxiang: 1 article (10/2008)
9. Wu, Daqing: 1 article (10/2008)
10. Zayzafoon, Majd: 1 article (10/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. Prostate-Specific Antigen (Semenogelase)
2. Survivin
3. Tyrosine (L-Tyrosine)
4. Diphosphonates (Bisphosphonates)
5. Amides

Related Therapies and Procedures

1. Aftercare (After-Treatment)